Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Tissue Transglutaminase, DGP TTG-DGP Screen Test is 7 days.

What are the prerequisites for the test Tissue Transglutaminase, DGP TTG-DGP Screen Test

  • Age: There are no age restrictions for this test.
  • Diet: The patient must be on a gluten-containing diet for at least 6 weeks before the test.
  • Medications: The patient should not be taking immunosuppressive medications that could affect the test results.
  • Pregnancy: The test can be performed during pregnancy, but the results may be affected by hormonal changes.
  • Medical history: The patient should inform the healthcare provider of any autoimmune disorders or other conditions that could affect the test results.

What are the measure values for the test Tissue Transglutaminase, DGP TTG-DGP Screen Test

  • Tissue Transglutaminase IgA: 0-19 U/mL (Negative), 20-30 U/mL (Weak Positive), >30 U/mL (Positive)
  • Deamidated Gliadin Peptide IgA: 0-19 U/mL (Negative), 20-30 U/mL (Weak Positive), >30 U/mL (Positive)
  • Deamidated Gliadin Peptide IgG: 0-19 U/mL (Negative), 20-30 U/mL (Weak Positive), >30 U/mL (Positive)

What does this test Tissue Transglutaminase, DGP TTG-DGP Screen Test identify?

The Tissue Transglutaminase, DGP TTG-DGP Screen Test is used to identify antibodies that are commonly found in individuals with celiac disease. Celiac disease is an autoimmune disorder that affects the small intestine and is triggered by the ingestion of gluten. The test detects the presence of antibodies against tissue transglutaminase (TTG) and deamidated gliadin peptides (DGP) in the blood, which are markers of celiac disease. Positive results from this test indicate a likelihood of celiac disease and may prompt further diagnostic testing and treatment.

Why is this test Tissue Transglutaminase, DGP TTG-DGP Screen Test taken?

Reasons for Taking Tissue Transglutaminase, DGP TTG-DGP Screen Test

The Tissue Transglutaminase, DGP TTG-DGP Screen Test is taken to diagnose and monitor celiac disease, an autoimmune disorder that affects the small intestine. Celiac disease is triggered by the consumption of gluten, a protein found in wheat, barley, and rye.

This test measures the levels of antibodies in the blood that are produced in response to gluten ingestion. Elevated levels of these antibodies, specifically tissue transglutaminase (TTG) and deamidated gliadin peptide (DGP), indicate an immune response to gluten and can help confirm a diagnosis of celiac disease.

Additionally, the TTG-DGP screen test is used to monitor the effectiveness of a gluten-free diet in managing celiac disease. Regular testing can help determine if the diet is successfully reducing antibody levels and improving intestinal health.

No FAQs available.

Customer Google Rating